How to detect previous exposure to Covid-19 through antibody testing, to better identify and understand community transmission
- Funded by MBIE New Zealand
- Total publications:1000 publications
Grant number: N/A
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$306,158.78Funder
MBIE New ZealandPrincipal Investigator
Dr. Nikki MorelandResearch Location
New ZealandLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
This project has focused on establishing a way to provide evidence that an individual has been previously exposed to Covid-19 by detecting the presence of virus antibodies in blood. Accurate antibody-based tests (also known as serological tests) will underpin multiple strands of the pandemic response including clinical diagnostics and efforts to understand transmission and the immune response to SARS-CoV-2. The assay platform for antibody testing will be established in the Infection and Immunity laboratories at the University of Auckland as part of a collaborative effort involving scientists and clinicians across the country. The Covid antigens are being produced by groups at Callaghan Innovation and in the School of Biological Sciences at the University of Auckland.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC